These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 32361001)

  • 1. Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes.
    Moreno-Eutimio MA; López-Macías C; Pastelin-Palacios R
    Microbes Infect; 2020; 22(4-5):226-229. PubMed ID: 32361001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS.
    Rokni M; Ghasemi V; Tavakoli Z
    Rev Med Virol; 2020 May; 30(3):e2107. PubMed ID: 32267987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century.
    da Costa VG; Moreli ML; Saivish MV
    Arch Virol; 2020 Jul; 165(7):1517-1526. PubMed ID: 32322993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronaviruses: Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects.
    Wielgat P; Rogowski K; Godlewska K; Car H
    Cells; 2020 Aug; 9(9):. PubMed ID: 32854433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model.
    Rockx B; Kuiken T; Herfst S; Bestebroer T; Lamers MM; Oude Munnink BB; de Meulder D; van Amerongen G; van den Brand J; Okba NMA; Schipper D; van Run P; Leijten L; Sikkema R; Verschoor E; Verstrepen B; Bogers W; Langermans J; Drosten C; Fentener van Vlissingen M; Fouchier R; de Swart R; Koopmans M; Haagmans BL
    Science; 2020 May; 368(6494):1012-1015. PubMed ID: 32303590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mathematical model of infection kinetics and its analysis for COVID-19, SARS and MERS.
    Liang K
    Infect Genet Evol; 2020 Aug; 82():104306. PubMed ID: 32278147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronaviruses: An Updated Overview of Their Replication and Pathogenesis.
    Wang Y; Grunewald M; Perlman S
    Methods Mol Biol; 2020; 2203():1-29. PubMed ID: 32833200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
    Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M
    J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.
    Rathnayake AD; Zheng J; Kim Y; Perera KD; Mackin S; Meyerholz DK; Kashipathy MM; Battaile KP; Lovell S; Perlman S; Groutas WC; Chang KO
    Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32747425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection.
    Netea MG; Giamarellos-Bourboulis EJ; Domínguez-Andrés J; Curtis N; van Crevel R; van de Veerdonk FL; Bonten M
    Cell; 2020 May; 181(5):969-977. PubMed ID: 32437659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
    Ahmed-Hassan H; Sisson B; Shukla RK; Wijewantha Y; Funderburg NT; Li Z; Hayes D; Demberg T; Liyanage NPM
    Front Immunol; 2020; 11():1979. PubMed ID: 32973803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19.
    Chu H; Chan JF; Wang Y; Yuen TT; Chai Y; Hou Y; Shuai H; Yang D; Hu B; Huang X; Zhang X; Cai JP; Zhou J; Yuan S; Kok KH; To KK; Chan IH; Zhang AJ; Sit KY; Au WK; Yuen KY
    Clin Infect Dis; 2020 Sep; 71(6):1400-1409. PubMed ID: 32270184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of RNA sequences derived from the coronavirus genome in human cells.
    Wakida H; Kawata K; Yamaji Y; Hattori E; Tsuchiya T; Wada Y; Ozaki H; Akimitsu N
    Biochem Biophys Res Commun; 2020 Jul; 527(4):993-999. PubMed ID: 32446559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extraordinary GU-rich single-strand RNA identified from SARS coronavirus contributes an excessive innate immune response.
    Li Y; Chen M; Cao H; Zhu Y; Zheng J; Zhou H
    Microbes Infect; 2013 Feb; 15(2):88-95. PubMed ID: 23123977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topological Analysis for Sequence Variability: Case Study on more than 2K SARS-CoV-2 sequences of COVID-19 infected 54 countries in comparison with SARS-CoV-1 and MERS-CoV.
    Sarkar JP; Saha I; Seal A; Maity D; Maulik U
    Infect Genet Evol; 2021 Mar; 88():104708. PubMed ID: 33421654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review.
    Nascimento Junior JAC; Santos AM; Quintans-Júnior LJ; Walker CIB; Borges LP; Serafini MR
    Expert Opin Ther Pat; 2020 Aug; 30(8):567-579. PubMed ID: 32429703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.
    Messina F; Giombini E; Agrati C; Vairo F; Ascoli Bartoli T; Al Moghazi S; Piacentini M; Locatelli F; Kobinger G; Maeurer M; Zumla A; Capobianchi MR; Lauria FN; Ippolito G;
    J Transl Med; 2020 Jun; 18(1):233. PubMed ID: 32522207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19.
    Yang N; Shen HM
    Int J Biol Sci; 2020; 16(10):1724-1731. PubMed ID: 32226290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of two human-to-human transmitted coronaviruses: Corona Virus Disease 2019 vs. Middle East Respiratory Syndrome Coronavirus.
    Xu P; Sun GD; Li ZZ
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5797-5809. PubMed ID: 32495918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.